Related references
Note: Only part of the references are listed.Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Targeting p27Kip1 protein: its relevance in the therapy of human cancer
Adriana Borriello et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1 through SKP2 in Human Leukemia Cells
Gabriel Bretones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Development of natural anti-tumor drugs by microorganisms
Chia-Che Chang et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2011)
Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
Vince D. Cataldo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer
Takeshi Yoshida et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib
Yan Xu et al.
CANCER BIOLOGY & THERAPY (2010)
New Insights on the Antitumoral Properties of Prodiginines
R. Perez-Tomas et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
Hui-Kuan Lin et al.
NATURE (2010)
Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1(+/-) mice
Hongbo Wang et al.
NATURE GENETICS (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression
Chia-Hsin Chan et al.
THESCIENTIFICWORLDJOURNAL (2010)
p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function
Shicheng Liu et al.
CANCER LETTERS (2009)
Prodigiosins as Anti Cancer Agents: Living Upto Their Name
R. Pandey et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer
Shahab Uddin et al.
LABORATORY INVESTIGATION (2009)
Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells
Jing-Yi Chen et al.
LEUKEMIA RESEARCH (2009)
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdh1-mediated Skp2 destruction
Daming Gao et al.
NATURE CELL BIOLOGY (2009)
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB
Hui-Kuan Lin et al.
NATURE CELL BIOLOGY (2009)
Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines
Tsing-Fen Ho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
Anupriya Agarwal et al.
BLOOD (2008)
Targeting the p27 E3 ligase SCFSkp2 results in p27-and Skp2-mediated cell-cycle arrest and activation of autophagy
Qing Chen et al.
BLOOD (2008)
Imatinib Mesylate Induces Quiescence in Gastrointestinal Stromal Tumor Cells through the CDH1-SKP2-p27Kip1 Signaling Axis
Ying Liu et al.
CANCER RESEARCH (2008)
Bortezornib (velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer
Shahab Uddin et al.
CANCER RESEARCH (2008)
p27Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells
Q. Wang et al.
CELL DEATH AND DIFFERENTIATION (2008)
EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein
Hsiu-Chen Huang et al.
ENDOCRINOLOGY (2008)
Molecular mechanisms of p21 and 27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells
Pai-Hue Pang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer
David Frescas et al.
NATURE REVIEWS CANCER (2008)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
The anticancer agent prodigiosin induces p21WAF1/C1P1 expression via transforming growth factor-beta receptor pathway
Vanessa Soto-Cerrato et al.
BIOCHEMICAL PHARMACOLOGY (2007)
被撤回的出版物: Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Retracted article. See vol. 88, pg. 390, 2015)
Yi-He Ling et al.
MOLECULAR PHARMACOLOGY (2007)
Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells
Maximilian Reichert et al.
CANCER RESEARCH (2007)
Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-30 activity in human breast cancer cells
Vanessa Soto-Cerrato et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The biosynthesis and regulation of bacterial prodiginines
Neil R. Williamson et al.
NATURE REVIEWS MICROBIOLOGY (2006)
1,25-Dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells
Yu-Chun Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
F-box protein Skp2: a novel transcriptional target of E2F
L Zhang et al.
ONCOGENE (2006)
Significance of Skp2 expression in primary breast cancer
H Sonoda et al.
CLINICAL CANCER RESEARCH (2006)
Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase
T Bashir et al.
NATURE (2004)
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
W Wei et al.
NATURE (2004)
Skp2-mediated degradation of p27 regulates progression into mitosis
K Nakayama et al.
DEVELOPMENTAL CELL (2004)
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K Nakayama et al.
EMBO JOURNAL (2000)